Free Trial

Liquidia Technologies (LQDA) Competitors

Liquidia Technologies logo
$27.68 +0.22 (+0.80%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$27.60 -0.07 (-0.27%)
As of 08/29/2025 06:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LQDA vs. STVN, IRTC, GKOS, BLCO, TMDX, SLNO, NVST, LIVN, WRBY, and INSP

Should you be buying Liquidia Technologies stock or one of its competitors? The main competitors of Liquidia Technologies include Stevanato Group (STVN), iRhythm Technologies (IRTC), Glaukos (GKOS), Bausch + Lomb (BLCO), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), and Inspire Medical Systems (INSP). These companies are all part of the "medical equipment" industry.

Liquidia Technologies vs. Its Competitors

Liquidia Technologies (NASDAQ:LQDA) and Stevanato Group (NYSE:STVN) are both mid-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, valuation, profitability, institutional ownership, earnings and analyst recommendations.

Liquidia Technologies has a beta of 0.22, meaning that its share price is 78% less volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.55, meaning that its share price is 45% less volatile than the S&P 500.

Stevanato Group has higher revenue and earnings than Liquidia Technologies. Liquidia Technologies is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Liquidia Technologies$14M170.21-$130.39M-$1.70-16.28
Stevanato Group€1.19B5.87€127.45M€0.5442.85

64.5% of Liquidia Technologies shares are owned by institutional investors. 30.1% of Liquidia Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Liquidia Technologies had 7 more articles in the media than Stevanato Group. MarketBeat recorded 11 mentions for Liquidia Technologies and 4 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.56 beat Liquidia Technologies' score of 1.32 indicating that Stevanato Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Liquidia Technologies
8 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Stevanato Group
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Stevanato Group has a net margin of 11.73% compared to Liquidia Technologies' net margin of -732.17%. Stevanato Group's return on equity of 10.34% beat Liquidia Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Liquidia Technologies-732.17% -232.96% -60.81%
Stevanato Group 11.73%10.34%6.21%

Liquidia Technologies currently has a consensus target price of $32.11, indicating a potential upside of 16.01%. Given Liquidia Technologies' stronger consensus rating and higher possible upside, equities analysts clearly believe Liquidia Technologies is more favorable than Stevanato Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Liquidia Technologies
1 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
2 Strong Buy rating(s)
3.00
Stevanato Group
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.83

Summary

Liquidia Technologies and Stevanato Group tied by winning 8 of the 16 factors compared between the two stocks.

Get Liquidia Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for LQDA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LQDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LQDA vs. The Competition

MetricLiquidia TechnologiesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$2.38B$3.08B$5.69B$9.74B
Dividend YieldN/A2.28%6.64%4.48%
P/E RatioN/A20.9283.1926.59
Price / Sales170.21352.35515.16159.07
Price / CashN/A43.5325.6628.92
Price / Book30.429.7811.766.08
Net Income-$130.39M-$54.01M$3.27B$265.93M
7 Day Performance5.45%0.10%1.13%0.36%
1 Month Performance56.56%8.52%8.30%5.58%
1 Year Performance191.06%7.03%62.26%19.67%

Liquidia Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LQDA
Liquidia Technologies
3.5433 of 5 stars
$27.68
+0.8%
$32.11
+16.0%
+191.1%$2.38B$14M0.0050Positive News
STVN
Stevanato Group
N/A€21.99
-2.8%
N/A+5.8%€6.66B€1.19B40.725,521Positive News
IRTC
iRhythm Technologies
1.3993 of 5 stars
$165.68
-2.0%
$162.64
-1.8%
+139.8%$5.43B$591.84M-56.552,000
GKOS
Glaukos
4.7628 of 5 stars
$91.78
-2.5%
$127.42
+38.8%
-28.4%$5.40B$383.48M-55.62780News Coverage
Positive News
BLCO
Bausch + Lomb
1.7584 of 5 stars
$14.57
-2.5%
$15.56
+6.8%
-10.9%$5.29B$4.79B-18.6713,500
TMDX
TransMedics Group
3.1093 of 5 stars
$114.97
-4.1%
$123.00
+7.0%
-31.6%$4.09B$441.54M59.57210News Coverage
Analyst Downgrade
SLNO
Soleno Therapeutics
4.4991 of 5 stars
$66.51
-3.0%
$115.09
+73.0%
+38.2%$3.64BN/A-16.0730Positive News
NVST
Envista
4.0547 of 5 stars
$21.15
-2.6%
$20.92
-1.1%
+15.8%$3.61B$2.55B66.1012,300News Coverage
Positive News
Analyst Downgrade
LIVN
LivaNova
1.5271 of 5 stars
$56.35
+0.8%
$59.71
+6.0%
+11.9%$3.05B$1.25B-14.492,900Positive News
WRBY
Warby Parker
1.877 of 5 stars
$26.18
-3.1%
$24.06
-8.1%
+75.4%$2.84B$771.32M-373.883,780News Coverage
Positive News
Analyst Upgrade
INSP
Inspire Medical Systems
4.981 of 5 stars
$93.20
-2.9%
$165.62
+77.7%
-47.8%$2.84B$802.80M53.881,246Positive News

Related Companies and Tools


This page (NASDAQ:LQDA) was last updated on 9/1/2025 by MarketBeat.com Staff
From Our Partners